<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Hypertension</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->


      <h1>Hypertension</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <!-- <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div> -->
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
<br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            
            <strong>Systemic Hypertension:</strong>
            <ul>
                <li>Defined as persistently elevated office <strong>systolic blood pressure (SBP) ‚â•140 mmHg</strong> and/or <strong>diastolic blood pressure (DBP) ‚â•90 mmHg</strong>, measured on at least two separate occasions, typically spaced at least 1‚Äì2 weeks apart.</li>
            </ul>
            
            <strong>Isolated Systolic Hypertension:</strong>
            <ul>
                <li>Defined as persistently elevated <strong>SBP ‚â•140 mmHg</strong> with a normal <strong>DBP (<90 mmHg)</strong>.</li>
                <li>This condition is more common in older adults due to decreased arterial compliance.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Epidemiology of Hypertension</a>
          </h2>
        </header>
        <div class='body'>

            <p>Hypertension is a significant global health challenge and a major contributor to the burden of <strong>cardiovascular diseases (CVDs)</strong>.</p>
            
            <ul>
                <li>
                    <strong>Global Perspective:</strong> In the 20th century, CVDs accounted for fewer than <strong>10% of deaths worldwide</strong>, rising to approximately <strong>30%</strong> today. A staggering <strong>80%</strong> of these deaths now occur in <strong>low- and middle-income countries</strong>.
                </li>
                <li>
                    <strong>Nigerian Context:</strong>
                    <ul>
                        <li>An estimated <strong>25%</strong> of Nigerians are hypertensive, primarily affecting the middle- and top-level workforce.</li>
                        <li>This has profound implications for national productivity and the economy.</li>
                        <li>
                            Hypertension accounts for <strong>30%</strong> of clinic visits among individuals aged <strong>45‚Äì64 years</strong> (Ogunniyi). This age group experiences approximately <strong>1,021 clinic visits per 1,000 individuals</strong> (Cherry, 2008).
                        </li>
                        <li>Emergency admissions linked to hypertension make up <strong>a quarter</strong> of cases in Nigerian hospitals (Ekere).</li>
                    </ul>
                </li>
            </ul>
            

            </div>
          </section>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>BHS Classification of Blood Pressure Levels</a>
          </h2>
        </header>
        <div class='body'>

            <br>

            <div class="table-container">
                <table class="note-table">

                <tr>
                  <th>Category</th>
                  <th>Systolic blood pressure (mmHg)</th>
                  <th>Diastolic blood pressure</th>
                </tr>
                <tr>
                  <td>Optimal blood pressure</td>
                  <td><120</td>
                  <td><80</td>
                </tr>
                <tr>
                  <td>Normal blood pressure</td>
                  <td><130</td>
                  <td><85</td>
                </tr>
                <tr>
                  <td>High-normal blood pressure</td>
                  <td>130-139</td>
                  <td>85-89</td>
                </tr>
                <tr>
                  <td>Grade 1 Hypertension (mild)</td>
                  <td>140-159</td>
                  <td>90-99</td>
                </tr>
                <tr>
                  <td>Grade 2 Hypertension (moderate)</td>
                  <td>160-179</td>
                  <td>100-109</td>
                </tr>
                <tr>
                  <td>Grade 3 Hypertension (severe)</td>
                  <td>&ge;180</td>
                  <td>&ge;110</td>
                </tr>
                <tr>
                  <td>Isolated Systolic Hypertension (Grade 1)</td>
                  <td>140-159</td>
                  <td><90</td>
                </tr>
                <tr>
                  <td>Isolated Systolic Hypertension (Grade 2)</td>
                  <td>&ge;160</td>
                  <td><90</td>
                </tr>
              </table>
              </div>


              <h4>Diagnosis of Hypertension (HTN)</h4>

              <p>Hypertension is diagnosed based on elevated blood pressure (BP) measured through various methods:</p>
              
              <ol>
                  <li>
                      <strong>Conventional Office BP Measurement:</strong>
                      <ul>
                          <li><strong>SBP ‚â•140 mmHg</strong> and/or <strong>DBP ‚â•90 mmHg</strong></li>
                      </ul>
                  </li>
                  <li>
                      <strong>Home BP Monitoring:</strong>
                      <ul>
                          <li><strong>SBP ‚â•135 mmHg</strong> and/or <strong>DBP ‚â•85 mmHg</strong></li>
                      </ul>
                  </li>
                  <li>
                      <strong>Ambulatory Blood Pressure Monitoring (ABPM):</strong>
                      <ul>
                          <li><strong>Daytime (awake):</strong> SBP ‚â•135 mmHg and/or DBP ‚â•85 mmHg</li>
                          <li><strong>Nighttime (asleep):</strong> SBP ‚â•120 mmHg and/or DBP ‚â•70 mmHg</li>
                          <li><strong>24-hour average:</strong> SBP ‚â•130 mmHg and/or DBP ‚â•80 mmHg</li>
                      </ul>
                  </li>
              </ol>

              
              
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Types of Hypertension</a>
          </h2>
        </header>
        <div class='body'>

            
            <ol>
                <li>
                    <strong>Primary/Essential Hypertension (90% of cases):</strong>
                    <ul>
                        <li>Multifactorial with <strong>genetic (40‚Äì60%)</strong> and environmental influences.</li>
                    </ul>
                </li>
                <li>
                    <strong>Secondary Hypertension:</strong>
                    <ul>
                        <li>Caused by an identifiable underlying condition.</li>
                    </ul>
                </li>
            </ol>
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Aetiology and Risk Factors of Hypertension</a>
          </h2>
        </header>
        <div class='body'>

            <ol>
                <li>
                    <strong>Essential Hypertension (Primary Hypertension):</strong>
                    <ul>
                        <li>Accounts for <strong>90‚Äì95%</strong> of hypertension cases.</li>
                        <li>It is multifactorial, with both genetic and environmental influences:</li>
                        <ul>
                            <li>
                                <strong>Genetic Predisposition:</strong>
                                <ul>
                                    <li>Normal parents: Offspring risk = <strong>2.6%</strong>.</li>
                                    <li>One hypertensive parent: Risk doubles to <strong>5.7%</strong>.</li>
                                    <li>Both hypertensive parents: Risk increases tenfold to <strong>27.2%</strong>.</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Environmental and Lifestyle Factors:</strong>
                                <ul>
                                    <li>Obesity</li>
                                    <li>Low birth weight (fetal factors)</li>
                                    <li><strong>Metabolic Syndrome (Syndrome X):</strong> Combination of hypertension, diabetes mellitus, dyslipidemia, and obesity.</li>
                                </ul>
                            </li>
                        </ul>
                    </ul>
                </li>
                <li>
                    <strong>Secondary Hypertension:</strong>
                    <ul>
                        <li>Accounts for <strong>5‚Äì10%</strong> of hypertension cases.</li>
                        <li>Occurs due to identifiable underlying causes, including:</li>
                        <ul>
                            <li>
                                <strong>Lifestyle-Related Factors:</strong>
                                <ul>
                                    <li>Excessive alcohol consumption</li>
                                    <li>Obesity</li>
                                    <li>Pregnancy-induced hypertension</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Renal Causes:</strong>
                                <ul>
                                    <li>Renovascular disease (e.g., renal artery stenosis)</li>
                                    <li>Chronic kidney disease</li>
                                    <li>Glomerulonephritis</li>
                                    <li>Polycystic kidney disease</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Endocrine Disorders:</strong>
                                <ul>
                                    <li>Thyrotoxicosis</li>
                                    <li>Pheochromocytoma</li>
                                    <li>Cushing's syndrome</li>
                                    <li>Conn's syndrome (Primary hyperaldosteronism)</li>
                                    <li>Secondary hyperaldosteronism</li>
                                    <li>Congenital adrenal hyperplasia</li>
                                    <li>Hyperparathyroidism</li>
                                    <li>Acromegaly</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Drug-Induced Hypertension:</strong>
                                <ul>
                                    <li>Oral contraceptive pills (OCP)</li>
                                    <li>Estrogens</li>
                                    <li>Anabolic steroids/Chronic steroid therapy</li>
                                    <li>Corticosteroids</li>
                                    <li>Nonsteroidal anti-inflammatory drugs (NSAIDs)</li>
                                    <li>Sympathomimetics</li>
                                    <li>Carbenoxolone</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Cardiovascular Causes:</strong>
                                <ul>
                                    <li>Coarctation of the aorta</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Other Causes:</strong>
                                <ul>
                                    <li>Sleep apnea</li>
                                </ul>
                            </li>
                        </ul>
                    </ul>
                </li>
            </ol>
            
            <h4>Special Consideration</h4>
            
            <ul>
                <li>
                    <strong>White Coat Hypertension:</strong>
                    <ul>
                        <li>Elevated BP due to anxiety in clinical settings.</li>
                        <li>Confirm diagnosis using Home BP Monitoring (<strong>‚â•135/85 mmHg</strong>) or Ambulatory BP Monitoring (ABPM).</li>
                    </ul>
                </li>
            </ul>
            
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Target Organ Damage in Hypertension</a>
          </h2>
        </header>
        <div class='body'>

            <ol>
                <li>
                    <strong>Blood Vessels:</strong>
                    <ul>
                        <li>
                            <strong>Arterial Wall Thickening:</strong>
                            <ul>
                                <li>Atherosclerosis</li>
                                <li>Widespread atheroma contributing to Coronary Artery Disease (CAD) and Cerebrovascular Disease (CVD), particularly in individuals with risk factors such as smoking, diabetes mellitus (DM), or hyperlipidemia.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Aortic Pathologies:</strong>
                            <ul>
                                <li>Aortic aneurysm</li>
                                <li>Aortic dissection</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Note:</strong> Increased peripheral resistance reduces renal blood flow, activating the Renin-Angiotensin-Aldosterone System (RAAS), perpetuating hypertension.
                        </li>
                    </ul>
                </li>
                <li>
                    <strong>Central Nervous System (CNS):</strong>
                    <ul>
                        <li>Carotid Atheroma</li>
                        <li>Transient Ischaemic Attack (TIA)</li>
                        <li>
                            <strong>Stroke:</strong>
                            <ul>
                                <li>Due to haemorrhage or infarction</li>
                            </ul>
                        </li>
                        <li>Subarachnoid Haemorrhage (SAH)</li>
                        <li>
                            <strong>Hypertensive Encephalopathy:</strong>
                            <ul>
                                <li>Defined as severe hypertension with neurological symptoms:</li>
                                <ul>
                                    <li>Drowsiness, altered sensorium</li>
                                    <li>Transient disturbances of speech/vision</li>
                                    <li>Paraesthesia, disorientation</li>
                                    <li>Seizures, loss of consciousness (LOC)</li>
                                    <li>Papilledema</li>
                                </ul>
                            </ul>
                        </li>
                        <li><strong>Note:</strong> Neurological deficits are reversible with effective BP control.</li>
                    </ul>
                </li>
                <li>
                    <strong>Retina (Hypertensive Retinopathy):</strong>
                    <ul>
                        <li>
                            <strong>Graded based on severity:</strong>
                            <ul>
                                <li>
                                    <strong>Grade 1:</strong>
                                    <ul>
                                        <li>Arterial thickening, tortuosity, and increased reflectiveness (termed "silver wiring").</li>
                                    </ul>
                                </li>
                                <li>
                                    <strong>Grade 2:</strong>
                                    <ul>
                                        <li>Grade 1 findings + arteriovenous (AV) nipping (compression of veins by thickened arteries).</li>
                                    </ul>
                                </li>
                                <li>
                                    <strong>Grade 3:</strong>
                                    <ul>
                                        <li>Grade 2 findings + evidence of retinal ischaemia, such as:</li>
                                        <ul>
                                            <li>Flame or blot haemorrhages</li>
                                            <li>Cotton wool spots/soft exudates</li>
                                        </ul>
                                    </ul>
                                </li>
                                <li>
                                    <strong>Grade 4:</strong>
                                    <ul>
                                        <li>Grade 3 findings + papilledema (optic disc swelling).</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li><strong>Note:</strong> Grades 3 and 4 hypertensive retinopathy are diagnostic of malignant hypertension. Hypertension is also associated with central retinal vein thrombosis.</li>
                    </ul>
                </li>
                <li>
                    <strong>Heart:</strong>
                    <ul>
                        <li>Coronary Artery Disease (CAD)</li>
                        <li>Left Ventricular Hypertrophy (LVH): A marker of cardiovascular risk.</li>
                        <li>Atrial Fibrillation: Can result from LVH or CAD.</li>
                        <li>
                            <strong>Heart Failure:</strong>
                            <ul>
                                <li>Most commonly left ventricular failure.</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li>
                    <strong>Kidneys:</strong>
                    <ul>
                        <li>Proteinuria</li>
                        <li>Progressive Renal Failure</li>
                        <li>Hypertensive Nephrosclerosis</li>
                    </ul>
                </li>
            </ol>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'> Management of Hypertension</a>
          </h2>
        </header>
        <div class='body'>

            <section id='heading-7-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-1'>History Taking in Hypertension</a>
                  </h3>
                </header>
                <div class='body'>
            
                    <ol>
                        <li>
                            <strong>Presenting Complaints:</strong>
                            <ul>
                                <li>
                                    <strong>Common Presentation:</strong>
                                    <ul>
                                        <li>Often asymptomatic, detected during routine checks.</li>
                                        <li>Non-specific symptoms may include headache, weakness, and insomnia.</li>
                                    </ul>
                                </li>
                                <li>
                                    <strong>Symptoms Suggestive of Underlying Causes:</strong>
                                    <ul>
                                        <li><strong>Pheochromocytoma:</strong> Paroxysmal headaches, palpitations.</li>
                                        <li><strong>Thyrotoxicosis:</strong> Proptosis with or without goiter.</li>
                                    </ul>
                                </li>
                                <li>
                                    <strong>Complications:</strong>
                                    <ul>
                                        <li>Symptoms typically result from target organ damage:</li>
                                        <ul>
                                            <li><strong>Neurological:</strong> Stroke, hypertensive encephalopathy.</li>
                                            <li><strong>Cardiovascular:</strong> Chest pain, myocardial infarction.</li>
                                            <li><strong>Renal:</strong> Reduced urine output, proteinuria.</li>
                                        </ul>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li>
                            <strong>History of Presenting Complaint (HPC):</strong>
                            <ul>
                                <li><strong>Complaint:</strong> Clarify symptoms and their onset.</li>
                                <li><strong>Course:</strong> Understand the progression and fluctuations.</li>
                                <li><strong>Causes:</strong> Explore potential underlying conditions (e.g., endocrine, renal, or cardiovascular).</li>
                                <li>
                                    <strong>Complications:</strong> Probe for signs of organ damage:
                                    <ul>
                                        <li>Vision disturbances, chest pain, breathlessness, or neurological deficits.</li>
                                    </ul>
                                </li>
                                <li><strong>Care so far:</strong> Ask about prior evaluations, medications, or treatments.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Past Medical History (PMH):</strong>
                            <ul>
                                <li>Investigate the presence of:</li>
                                <ul>
                                    <li>Chronic conditions like diabetes or renal disorders (e.g., glomerulonephritis, polycystic kidney disease).</li>
                                    <li>Pregnancy-related complications such as preeclampsia or eclampsia.</li>
                                </ul>
                            </ul>
                        </li>
                        <li>
                            <strong>Family History:</strong>
                            <ul>
                                <li>Look for a family history of:</li>
                                <ul>
                                    <li>Hypertension</li>
                                    <li>Diabetes Mellitus</li>
                                    <li>Polycystic Kidney Disease (PKD)</li>
                                </ul>
                            </ul>
                        </li>
                        <li>
                            <strong>Social History:</strong>
                            <ul>
                                <li>Smoking habits</li>
                                <li>Alcohol consumption</li>
                                <li>High-cholesterol diet</li>
                                <li>Exercise habits</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Drug History:</strong>
                            <ul>
                                <li>Explore use of medications or substances that may contribute to hypertension:</li>
                                <ul>
                                    <li>Sympathomimetics</li>
                                    <li>Oral contraceptives</li>
                                    <li>NSAIDs</li>
                                </ul>
                            </ul>
                        </li>
                        <li>
                            <strong>Systemic Review:</strong> Conduct a detailed review of all systems to uncover any hidden symptoms or complications.
                        </li>
                    </ol>
    
                </div>
              </section>

              <section id='heading-7-2'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-2'>Physical Examination Approach</a>
                  </h3>
                </header>
                <div class='body'>

                    <p><strong>Always follow the "IPPA" approach:</strong></p>
                    <ul>
                        <li>Inspection</li>
                        <li>Palpation</li>
                        <li>Percussion</li>
                        <li>Auscultation</li>
                    </ul>
                    
                    <h4>General Examination</h4>
                    <ul>
                        <li>
                            <strong>Weight and Height:</strong>
                            <ul>
                                <li>To calculate Body Mass Index (BMI) and assess for obesity.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Characteristic Features:</strong>
                            <ul>
                                <li><strong>Cushing's syndrome:</strong> Moon-shaped face, red cheeks.</li>
                                <li><strong>Thyrotoxicosis:</strong> Bulging eyes (proptosis), goitre.</li>
                                <li><strong>Hyperlipidaemia:</strong> Xanthomas, atheromas (e.g., around the eyes).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Routine General Examination:</strong>
                            <ul>
                                <li>Essentially normal in essential hypertension unless there are signs of organ damage or secondary causes.</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <h4>Cardiovascular System (CVS)</h4>
                    <ul>
                        <li>
                            <strong>Pulse:</strong>
                            <ul>
                                <li>Regularity, rate, and rhythm.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Blood Pressure (BP):</strong>
                            <ul>
                                <li>Elevated BP >140/90 mmHg (diagnostic of hypertension).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Jugular Venous Pressure (JVP):</strong>
                            <ul>
                                <li>Elevated JVP or distended neck veins suggest heart failure.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Precordial Examination:</strong>
                            <ul>
                                <li>Locomotor brachialis (sign of arterial stiffness).</li>
                                <li>Radioradial/radiofemoral delay: Suggestive of coarctation of the aorta.</li>
                                <li>Irregularly irregular pulse: Seen in atrial fibrillation.</li>
                                <li>Small volume pulse: Indicative of heart failure.</li>
                                <li>Apical heave: Suggestive of left ventricular hypertrophy (LVH).</li>
                                <li>Loud A2: Increased intensity of the second heart sound, indicative of systemic hypertension.</li>
                                <li>S4 or S3 heart sounds: Present in heart failure.</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <h4>Abdominal Examination</h4>
                    <ul>
                        <li>
                            <strong>Distended Abdomen:</strong>
                            <ul>
                                <li>Associated with central obesity (metabolic syndrome).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Striae:</strong>
                            <ul>
                                <li>Purple striae in Cushing's syndrome.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Pulsating Abdominal Mass:</strong>
                            <ul>
                                <li>Suggestive of aortic aneurysm.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Enlarged Kidney:</strong>
                            <ul>
                                <li>May suggest Polycystic Kidney Disease (PKD).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Renal Bruit:</strong>
                            <ul>
                                <li>Suggestive of renal artery stenosis (RAS).</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <h4>Fundoscopy</h4>
                    <p>Examine the retina to assess for hypertensive retinopathy and determine the extent of damage (Grades 1-4):</p>
                    <ul>
                        <li><strong>Grade 1:</strong> Arterial thickening, tortuosity.</li>
                        <li><strong>Grade 2:</strong> Arteriovenous nipping.</li>
                        <li><strong>Grade 3:</strong> Retinal ischaemia, cotton wool spots, and haemorrhages.</li>
                        <li><strong>Grade 4:</strong> Papilledema (indicative of malignant hypertension).</li>
                    </ul>
                    
                    <h4>Features of Long-standing Hypertension</h4>
                    <ul>
                        <li>Locomotor brachialis (stiffening of arteries).</li>
                        <li>Thickened arterial wall.</li>
                        <li>Displaced apex beat (due to LVH).</li>
                        <li>Loud A2 (heart sound).</li>
                        <li>Grade II hypertensive retinopathy or higher.</li>
                    </ul>
                    
                </div>
              </section>

              <section id='heading-7-3'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-3'>Investigations in Hypertension</a>
                  </h3>
                </header>
                <div class='body'>

                    <h4>Specific Investigations</h4>
                    <ol>
                        <li>
                            <strong>12-Lead ECG:</strong>
                            <ul>
                                <li>Detects atrial fibrillation, chamber enlargement (e.g., left ventricular hypertrophy (LVH)), and signs of coronary artery disease (CAD).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Chest X-ray:</strong>
                            <ul>
                                <li>Assesses for cardiomegaly (cardiothoracic ratio [CTR] >50%) and signs of heart failure (e.g., unfolding of the aorta).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Echocardiogram (Echo):</strong>
                            <ul>
                                <li>Evaluates for LVH and assesses ejection fraction (<0.4 indicates heart failure).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Ambulatory Blood Pressure Monitoring (ABPM):</strong>
                            <ul>
                                <li>Provides a 24-hour BP profile; add 10/5 mmHg to the average ambulatory BP reading to estimate clinic BP value.</li>
                            </ul>
                        </li>
                    </ol>
                    
                    <h4>General Investigations</h4>
                    <ol>
                        <li>
                            <strong>Urinalysis:</strong>
                            <ul>
                                <li>Check for blood, protein, and glucose to assess for renal involvement or diabetes.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Electrolytes, Urea, and Creatinine (E, U/Cr):</strong>
                            <ul>
                                <li><strong>Potassium (K):</strong> Elevated in Conn's syndrome (primary hyperaldosteronism).</li>
                                <li><strong>Calcium (Ca¬≤‚Å∫):</strong> Elevated in hyperparathyroidism.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Blood Glucose Testing:</strong>
                            <ul>
                                <li>Fasting Blood Sugar (FBS) or Random Blood Sugar (RBS) to rule out diabetes mellitus (DM).</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Serum Cholesterol Levels:</strong>
                            <ul>
                                <li>Total cholesterol and HDL cholesterol to screen for hyperlipidaemia.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Renal Ultrasound (Renal USS):</strong>
                            <ul>
                                <li>To rule out renal disease such as polycystic kidney disease (PKD) or other structural abnormalities.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Renal Angiography:</strong>
                            <ul>
                                <li>To rule out renal artery stenosis (RAS), a common cause of secondary hypertension.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>24-Hour Urinary Metanephrines:</strong>
                            <ul>
                                <li>To rule out pheochromocytoma, a tumour of the adrenal medulla that can cause secondary hypertension.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Urinary Cortisol and Dexamethasone Suppression Test:</strong>
                            <ul>
                                <li>To rule out Cushing's syndrome, characterized by excess cortisol production.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>Plasma Renin Activity & Aldosterone:</strong>
                            <ul>
                                <li>To rule out primary aldosteronism, a condition caused by excess aldosterone.</li>
                            </ul>
                        </li>
                        <li>
                            <strong>CT Scan:</strong>
                            <ul>
                                <li><strong>Brain CT:</strong> To assess for haemorrhage in and around the basal ganglia, which may suggest hypertensive encephalopathy.</li>
                                <li><strong>Abdominal CT:</strong> To identify adrenal masses that may indicate pheochromocytoma.</li>
                            </ul>
                        </li>
                    </ol>
                    

                                <!-- image here -->
            <div class="image-container">
                <img src="../figures/" alt="" onclick="openModal(this)">
                <div class="caption">Routine investigations</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Routine investigations</div>
              </div>
    
                </div>
              </section>

              <section id='heading-7-4'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-7-4'>Treatment of Hypertension</a>
                  </h3>
                </header>
                <div class='body'>

                    <h4>Indications for Treatment</h4>
                    <ul>
                        <li>Offer treatment if:
                            <ul>
                                <li>BP ‚â•160/100 mmHg</li>
                                <li>Isolated systolic hypertension with SBP ‚â•160 mmHg</li>
                                <li>BP >140/90 mmHg and CVD risk ‚â•20%, or existing CVD or target organ damage.</li>
                            </ul>
                        </li>
                    </ul>
                    
                    <h4>Target BP Goals</h4>
                    <ul>
                        <li>Clinic BP ‚â§140/90 mmHg</li>
                        <li><strong><130/80 mmHg</strong> in diabetic patients</li>
                        <li><strong><150/90 mmHg</strong> if aged 80 or older</li>
                    </ul>
                    
                    <h4>Monitoring</h4>
                    <ul>
                        <li>Schedule 3-monthly clinic appointments to monitor BP, minimize side effects of medications, and reinforce lifestyle advice.</li>
                    </ul>
                    
            <!-- image here -->
            <div class="image-container">
                <img src="../figures/hypertension-2 (1).png" alt="" onclick="openModal(this)">
                <div class="caption">Hypertension guideline management algorithm</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Hypertension guideline management algorithm</div>
              </div>

                    <section id='heading-7-4-1'>
                        <header>
                          <h3>
                            <a aria-hidden href='#heading-7-4-1'>Non-Drug Therapy (Lifestyle Modification)</a>
                          </h3>
                        </header>
                        <div class='body'>
                            <p>The aim is to:</p>
                            <ul>
                                <li>Prevent the need for medications,</li>
                                <li>Use lower doses of medications in established cases,</li>
                                <li>Reduce CVD risk.</li>
                            </ul>
                            
                            <p>Key lifestyle changes include:</p>
                            <ul>
                                <li>Correct obesity through diet and exercise.</li>
                                <li>Reduce alcohol intake.</li>
                                <li>Restrict salt intake to &lt;2g/day.</li>
                                <li>Regular physical exercise: At least 30 minutes of brisk walking 5 times a week.</li>
                                <li>Increase consumption of fruits and vegetables.</li>
                                <li>Quit smoking and follow a diet low in saturated fat; eat fish to further reduce CVD risk.</li>
                            </ul>
                            
                            <h4>Benefits of Lifestyle Modification in Hypertension Management</h4>
                            <p>Lifestyle modification is a cornerstone in managing hypertension, offering effective, low-cost, and wide-reaching benefits. Below are key strategies and their impact:</p>
                            <ul>
                                <li><strong>Weight Reduction</strong>
                                    <ul>
                                        <li>Target: Maintain a BMI of 18.5‚Äì24.9.</li>
                                        <li>BP Reduction: 5‚Äì20 mmHg per 10 kg weight loss.</li>
                                        <li>Additional Benefits: Improves insulin sensitivity, reduces cardiovascular risk.</li>
                                    </ul>
                                </li>
                                <li><strong>Dietary Modifications</strong>
                                    <ul>
                                        <li><strong>DASH Diet:</strong>
                                            <ul>
                                                <li>Emphasizes fruits, vegetables, low-fat dairy, and reduced saturated fats.</li>
                                                <li>BP Reduction: 8‚Äì14 mmHg.</li>
                                            </ul>
                                        </li>
                                        <li><strong>Sodium Reduction:</strong>
                                            <ul>
                                                <li>Limit intake to 2.4 g sodium (6 g salt) daily.</li>
                                                <li>BP Reduction: 2‚Äì8 mmHg.</li>
                                            </ul>
                                        </li>
                                    </ul>
                                </li>
                                <li><strong>Physical Activity</strong>
                                    <ul>
                                        <li>Recommendation: Regular aerobic exercise (e.g., brisk walking) for at least 30 minutes most days.</li>
                                        <li>BP Reduction: 4‚Äì9 mmHg.</li>
                                        <li>Additional Benefits: Enhances cardiovascular health and metabolic function.</li>
                                    </ul>
                                </li>
                                <li><strong>Smoking Cessation</strong>
                                    <ul>
                                        <li>Impact: Minimal direct effect on BP but significantly reduces overall cardiovascular risk.</li>
                                        <li>Advice: Counsel all hypertensive smokers to quit.</li>
                                    </ul>
                                </li>
                            </ul>


                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/hypertension-2 (2).png" alt="" onclick="openModal(this)">
                <div class="caption">Lifestyle modifications to manage hypertension</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Lifestyle modifications to manage hypertension</div>
              </div>
                            
            
                        </div>
                      </section>

                      <section id='heading-7-4-2'>
                        <header>
                          <h3>
                            <a aria-hidden href='#heading-7-4-2'>Drug Therapy (Antihypertensive Drugs)</a>
                          </h3>
                        </header>
                        <div class='body'>

                            <p><strong>1. Thiazides and Diuretics:</strong></p>
                            <ul>
                                <li>Bendroflumethiazide (2.5 mg daily)</li>
                                <li>Cyclopenthiazide (0.5 mg daily)</li>
                                <li>Furosemide (40 mg daily) or Bumetanide (1 mg daily).</li>
                                <li><strong>Note:</strong> Loop diuretics are poor antihypertensives.</li>
                                <li>Thiazide-like diuretics (e.g., Indapamide) are preferred.</li>
                            </ul>
                            
                            <p><strong>2. Angiotensin-Converting Enzyme Inhibitors (ACEIs):</strong></p>
                            <ul>
                                <li>Enalapril (20 mg daily)</li>
                                <li>Ramipril (5-10 mg daily)</li>
                                <li>Lisinopril (10-40 mg daily).</li>
                                <li><strong>Caution:</strong> In patients with impaired renal function or renal artery stenosis. Check E, U/Cr before starting and 1-2 weeks after initiation.</li>
                                <li><strong>Side effects:</strong> First-dose hypotension, cough, rash, hyperkalemia, and renal dysfunction.</li>
                            </ul>
                            
                            <p><strong>3. Angiotensin Receptor Blockers (ARBs):</strong></p>
                            <ul>
                                <li>Valsartan (40-160 mg daily).</li>
                                <li><strong>Advantage:</strong> Fewer side effects compared to ACEIs.</li>
                            </ul>
                            
                            <p><strong>4. Calcium Channel Blockers (CCBs):</strong></p>
                            <ul>
                                <li><strong>Dihydropyridines:</strong> (e.g., Amlodipine 5-10 mg daily, Nifedipine 30-90 mg daily).
                                    <ul>
                                        <li>Useful in the elderly.</li>
                                        <li><strong>Side effects:</strong> Flushing, palpitations, fluid retention.</li>
                                    </ul>
                                </li>
                                <li><strong>Non-dihydropyridines:</strong> (e.g., Diltiazem 200-300 mg daily, Verapamil 240 mg daily).
                                    <ul>
                                        <li>Particularly useful in ischemic heart disease.</li>
                                    </ul>
                                </li>
                            </ul>
                            
                            <p><strong>5. Beta-Blockers (B-blockers):</strong></p>
                            <ul>
                                <li>Not used as first-line therapy except for patients with specific indications, such as angina.</li>
                                <li><strong>Examples:</strong>
                                    <ul>
                                        <li>Metoprolol (100-200 mg daily)</li>
                                        <li>Atenolol (50-100 mg daily)</li>
                                        <li>Bisoprolol (5-10 mg daily).</li>
                                    </ul>
                                </li>
                            </ul>
                            
                            <p><strong>6. Alpha-Blockers:</strong></p>
                            <ul>
                                <li>Prazosin, Doxazosin.</li>
                            </ul>
                            
                            <p><strong>7. Other Vasodilators:</strong></p>
                            <ul>
                                <li>Hydralazine, Minoxidil.</li>
                                <li>Used in severe hypertension or cases with poor response to other treatments.</li>
                            </ul>
                            
                            <p><strong>8. Centrally Acting Drugs:</strong></p>
                            <ul>
                                <li>Medications that act on the central nervous system to reduce BP.</li>
                            </ul>
                            
                            <p><strong>9. Labetalol and Carvedilol:</strong></p>
                            <ul>
                                <li>Labetalol: 200 mg-2.4 g daily (in divided doses).</li>
                                <li>Carvedilol: 6.25-25 mg 12-hourly.</li>
                                <li>Labetalol infusion is used in malignant hypertension.</li>
                            </ul>
                            
                            <h4>Stepwise Use of Antihypertensive Drugs</h4>
                            
                            <p><strong>1. Step 1: Initial Treatment</strong></p>
                            <ul>
                                <li>Calcium Channel Blockers (CCBs) or Diuretics: Start with either a CCB (e.g., Amlodipine) or a diuretic (e.g., Indapamide or Bendroflumethiazide) as the first-line treatment.</li>
                            </ul>
                            
                            <p><strong>2. Step 2: Add a Second Drug</strong></p>
                            <ul>
                                <li>ACE Inhibitors (ACEI) or Angiotensin Receptor Blockers (ARBs): Combine either an ACEI (e.g., Enalapril, Ramipril) or an ARB (e.g., Valsartan) with the initial drug (i.e., A + C or A + D).</li>
                            </ul>
                            
                            <p><strong>3. Step 3: Add a Third Drug</strong></p>
                            <ul>
                                <li>Three-drug combination: If blood pressure control is not achieved, add a third drug from the following classes:
                                    <ul>
                                        <li>ACEI/ARB + CCB + Diuretic (i.e., A + C + D).</li>
                                    </ul>
                                </li>
                            </ul>
                            
                            <p><strong>4. Step 4: Add Additional Drugs and Consider Specialist Referral</strong></p>
                            <ul>
                                <li>Further Diuretics (e.g., Spironolactone).</li>
                                <li>Alpha Blockers (e.g., Prazosin, Doxazosin).</li>
                                <li>Beta-Blockers (e.g., Metoprolol, Atenolol).</li>
                                <li>If blood pressure remains poorly controlled despite optimal doses of these drugs, consider specialist referral.</li>
                            </ul>
                            

                                        <!-- image here -->
            <div class="image-container">
                <img src="../figures/hypertension-2 (4).png" alt="" onclick="openModal(this)">
                <div class="caption">Clinical trial and guideline basis for compelling indications for individual drug classes</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Clinical trial and guideline basis for compelling indications for individual drug classes</div>
              </div>



                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/hypertension-2 (5).png" alt="" onclick="openModal(this)">
                <div class="caption">Compelling and possible indications contraindications and cautions for the major classes</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Compelling and possible indications contraindications and cautions for the major classes</div>
              </div>

                            <h4>Adjuvant Drug Therapy</h4>

                            <p><strong>1. Aspirin (Antiplatelet Therapy):</strong></p>
                            <ul>
                                <li><strong>Indication:</strong> Reduce CVD risk, particularly in patients with well-controlled BP and existing target organ damage, diabetes, or a 10-year CAD risk ‚â•15%.</li>
                                <li><strong>Risk:</strong> May increase the risk of bleeding, including intracerebral bleeding in some patients. The benefits generally outweigh the risks in those over 50 years old with well-controlled BP.</li>
                            </ul>
                            
                            <p><strong>2. Statins:</strong></p>
                            <ul>
                                <li><strong>Indication:</strong> Strongly indicated in patients with established vascular disease or a 10-year CVD risk ‚â•20% to reduce cholesterol and CVD risk.</li>
                                <li><strong>Note:</strong> Statins help to stabilize atherosclerotic plaques and reduce further cardiovascular events.</li>
                            </ul>
                            
                            <h4>How Long Are Antihypertensives Used For?</h4>
                            <ul>
                                <li>Lifelong for most people, especially in primary (essential) hypertension.</li>
                                <li>Temporary in secondary hypertension if the underlying cause is treated (e.g., surgery for a tumor).</li>
                                <li>Lifestyle changes can reduce the dose but rarely eliminate the need for medication.</li>
                            </ul>
                                        
                        </div>
                      </section>

                </div>
              </section>

 
            
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Resistant Hypertension </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
                <li><strong>Definition:</strong> Resistant hypertension is diagnosed when a patient‚Äôs systolic blood pressure remains poorly controlled despite adherence to optimal doses of at least three classes of antihypertensive drugs, including a diuretic. If blood pressure control is still not achieved, the use of four or more drugs may be necessary.</li>
            </ul>
            
            <h4> Causes</h4>
            <ul>
                <li>Nonadherence</li>
                <li>Inadequate doses</li>
                <li>Inappropriate combinations</li>
                <li>Drugs: NSAID, Cocaine, amphetamines</li>
                <li>Sympathomimetics (decongestants, anorectics)</li>
                <li>Obesity</li>
                <li>Excess alcohol intake</li>
                <li>Contraceptives</li>
                <li>Erythropoetin</li>
                <li>Secondary causes of hypertension</li>
                <li>Improper BP measurement</li>
                <li>OTC interactions</li>
                <li>Inadequate diuresis</li>
            </ul>
            
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Hypertensive Emergency </a>
          </h2>
        </header>
        <div class='body'>
            <p>A hypertensive emergency is characterized by a markedly elevated blood pressure (BP ‚â•180/120 mmHg) with acute end-organ damage that requires immediate intervention using parenteral antihypertensives over minutes to hours. It is more common in younger patients and Black individuals.</p>
            
            <h4>Target Organ Damage:</h4>
            <ul>
                <li><strong>Blood Vessels:</strong> 
                    <ul>
                        <li>Thickened arterial walls</li>
                        <li>Widespread atheroma causing Coronary Artery Disease (CAD), Cerebrovascular Disease (CVD)</li>
                    </ul>
                </li>
                <li><strong>CNS (Central Nervous System):</strong>
                    <ul>
                        <li>Stroke (from hemorrhage or infarction)</li>
                        <li>Transient Ischemic Attack (TIA)</li>
                        <li>Subarachnoid Hemorrhage (SAH)</li>
                        <li>Hypertensive Encephalopathy</li>
                    </ul>
                </li>
                <li><strong>Retina:</strong>
                    <ul>
                        <li>Hypertensive Retinopathy: retinal hemorrhages, exudates, and possibly papilledema</li>
                    </ul>
                </li>
                <li><strong>Heart:</strong>
                    <ul>
                        <li>Coronary Artery Disease (CAD)</li>
                        <li>Left Ventricular Hypertrophy (LVH)</li>
                        <li>Atrial Fibrillation following LVH or CAD</li>
                        <li>Heart Failure, especially Left Ventricular Failure (LVF)</li>
                    </ul>
                </li>
                <li><strong>Kidneys:</strong>
                    <ul>
                        <li>Proteinuria</li>
                        <li>Progressive renal failure</li>
                    </ul>
                </li>
            </ul>
            
            <h4>Hypertensive Urgency vs. Emergency</h4>
            <ul>
                <li><strong>Hypertensive Emergency:</strong> BP ‚â•180/120 mmHg with acute end-organ damage. Requires immediate parenteral antihypertensives.</li>
                <li><strong>Hypertensive Urgency:</strong> BP ‚â•180/120 mmHg without acute organ damage. Managed with oral antihypertensives over hours to days. Avoid sudden drops in BP due to poor cerebral autoregulation, increasing stroke risk.</li>
            </ul>
            
            <h4>Malignant Hypertension & Accelerated Hypertension</h4>

            <ul>
                <li><strong>Malignant Hypertension:</strong>
                    <ul>
                        <li>Rare, but severe, form of hypertensive emergency characterized by:</li>
                        <ul>
                            <li>Severe hypertension</li>
                            <li>Rapidly progressive end-organ damage</li>
                            <li>Bilateral retinal hemorrhages and exudates, ¬± papilledema</li>
                            <li>Left ventricular failure (LVF) leading to death if untreated</li>
                        </ul>
                    </ul>
                </li>
                <li><strong>Accelerated Hypertension:</strong>
                    <ul>
                        <li>Recent significant increase over baseline BP associated with target organ damage.</li>
                    </ul>
                </li>
            </ul>
            
            <h4>Symptoms of Hypertensive Emergency</h4>
            <ul>
                <li>Headache</li>
                <li>Visual disturbances (e.g., blurred vision, blindness)</li>
                <li>May precipitate acute renal failure, heart failure, or encephalopathy.</li>
            </ul>
            
            <h4>Management of Hypertensive Emergency</h4>
            <ol>
                <li><strong>Admit to ICU:</strong>
                    <ul>
                        <li>Strict blood pressure monitoring</li>
                        <li>Frequent neurologic status assessment</li>
                        <li>Frequent urine output monitoring</li>
                    </ul>
                </li>
                <li><strong>IV Antihypertensive Therapy:</strong>
                    <ul>
                        <li><strong>Sodium Nitroprusside or Labetalol</strong> (for rapid control)
                            <ul>
                                <li>Sodium Nitroprusside: Start with 0.5 ¬µg/kg/min IV, titrate up to 8 ¬µg/kg/min</li>
                                <li>Labetalol: 50 mg IV over 1 minute, repeat every 5 minutes (max 300 mg/day)</li>
                            </ul>
                        </li>
                    </ul>
                </li>
                <li><strong>Blood Pressure Goals:</strong>
                    <ul>
                        <li>Reduce BP to a target of ~110 mmHg diastolic over the first 4 hours</li>
                        <li>MAP (Mean Arterial Pressure) should be reduced by 20-25% over 1-2 hours</li>
                        <li>Subsequent BP reduction over the next 24 hours</li>
                        <li>Maintain BP in the first 24 hours at no less than 160/110 mmHg</li>
                    </ul>
                </li>
                <li><strong>Avoid Use of Sublingual Nifedipine:</strong>
                    <ul>
                        <li>Never use sublingual nifedipine as it can cause a dangerous drop in BP and increase stroke risk.</li>
                    </ul>
                </li>
            </ol>
            
            <h4>Drugs Used in Hypertensive Emergency</h4>
            <ul>
                <li>Labetalol</li>
                <li>Nicardipine / Clevidipine</li>
                <li>Nitroprusside</li>
                <li>Nitroglycerin</li>
                <li>Urapidil</li>
                <li>Esmolol</li>
                <li>Phentolamine (used for pheochromocytoma crisis)</li>
            </ul>
            
            <h4>Notes:</h4>
            <ul>
                <li>Hydralazine may be used in pregnant women.</li>
                <li>After BP control, switch to oral antihypertensives for long-term management.</li>
            </ul>
            

        </div>
      </section>






      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <!-- <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div> -->

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://chat.whatsapp.com/FtDdb6uEFYzBCnTnMgm2Z1" class="comment-button">
            here
            <img src="../images/icons/whatsapp.png" alt="Image Icon">
          </a>
        </div>

        <div class="contributors-container">

          <!-- <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div> -->
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
